Novo and Dayforce Jumps; Apple Headset
On this episode of Stock Movers:- Novo Nordisk (NVO) shares advanced after the drugmaker's weight-loss drug Wegovy received US approval to treat a serious form of liver disease. The US Food and Drug Administration's decision "could start to help shift the momentum for Novo following a more difficult start to the year," according to Evan David Seigerman, an analyst at BMO Capital Markets.- Dayforce (DAY) shares are higher on news Thoma Bravo is in talks to acquire human resources management software provider Dayforce Inc., according to people familiar with the matter. The buyout firm is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.